These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20461084)

  • 41. A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
    Kong LY; Wei J; Sharma AK; Barr J; Abou-Ghazal MK; Fokt I; Weinberg J; Rao G; Grimm E; Priebe W; Heimberger AB
    Cancer Immunol Immunother; 2009 Jul; 58(7):1023-32. PubMed ID: 19002459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
    Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
    Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Signal transducers and activators of transcription-3 modulates human squamous cell carcinoma invasion via targeting mircoRNA-21 in vitro].
    Liu AQ; Li SS; Zhou X; Wang XD; Zhang L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Sep; 48(9):539-44. PubMed ID: 24314280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
    Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
    Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor and antiangiogenic activity of Schisandra chinensis polysaccharide in a renal cell carcinoma model.
    Qu HM; Liu SJ; Zhang CY
    Int J Biol Macromol; 2014 May; 66():52-6. PubMed ID: 24556120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.
    Tochizawa S; Masumori N; Yanai Y; Ohmoto Y; Yabuuchi Y; Tsukamoto T
    Biomed Res; 2008 Dec; 29(6):271-8. PubMed ID: 19129670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
    Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.
    Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH
    Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of Kinase Inhibitor WP1066 on the STAT3/JAK2 of Prostate Stromal Cells].
    Li YX; Li JM; Wei Q; Zhang ZP; Wu J; Wang AG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):65-68. PubMed ID: 29737092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPĪµ and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.
    Kim C; Baek SH; Um JY; Shim BS; Ahn KS
    BMC Nephrol; 2016 Feb; 17():19. PubMed ID: 26911335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
    Thompson JM; Nguyen QH; Singh M; Pavesic MW; Nesterenko I; Nelson LJ; Liao AC; Razorenova OV
    Oncogene; 2017 Feb; 36(8):1080-1089. PubMed ID: 27841867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
    Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
    Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
    Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
    Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
    Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
    Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
    Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
    Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting renal cell carcinoma with gambogic acid in combination with sunitinib in vitro and in vivo.
    Jiang XL; Zhang Y; Luo CL; Wu XH
    Asian Pac J Cancer Prev; 2012; 13(12):6463-8. PubMed ID: 23464475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed Administration of WP1066, an STAT3 Inhibitor, Ameliorates Radiation-Induced Lung Injury in Mice.
    Yu J; Yuan X; Liu Y; Zhang K; Wang J; Zhang H; Liu F
    Lung; 2016 Feb; 194(1):67-74. PubMed ID: 26563331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (-)-Oleocanthal exerts anti-melanoma activities and inhibits STAT3 signaling pathway.
    Gu Y; Wang J; Peng L
    Oncol Rep; 2017 Jan; 37(1):483-491. PubMed ID: 27878290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.